239 related articles for article (PubMed ID: 22491552)
1. Recombinant human bone morphogenetic protein-2 use in the off-label treatment of nonunions and acute fractures: a retrospective review.
Starman JS; Bosse MJ; Cates CA; Norton HJ
J Trauma Acute Care Surg; 2012 Mar; 72(3):676-81. PubMed ID: 22491552
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the clinical effectiveness of Bone Morphogenic Protein (BMP) -2 and -7 in the adjunct treatment of lower limb nonunions.
Haubruck P; Tanner MC; Vlachopoulos W; Hagelskamp S; Miska M; Ober J; Fischer C; Schmidmaier G
Orthop Traumatol Surg Res; 2018 Dec; 104(8):1241-1248. PubMed ID: 30293748
[TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic protein (BMP) for fracture healing in adults.
Garrison KR; Shemilt I; Donell S; Ryder JJ; Mugford M; Harvey I; Song F; Alt V
Cochrane Database Syst Rev; 2010 Jun; 2010(6):CD006950. PubMed ID: 20556771
[TBL] [Abstract][Full Text] [Related]
4. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions.
Friedlaender GE; Perry CR; Cole JD; Cook SD; Cierny G; Muschler GF; Zych GA; Calhoun JH; LaForte AJ; Yin S
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S151-8. PubMed ID: 11314793
[TBL] [Abstract][Full Text] [Related]
5. Treatment of critically sized femoral defects with recombinant BMP-2 delivered by a modified mPEG-PLGA biodegradable thermosensitive hydrogel.
Peng KT; Hsieh MY; Lin CT; Chen CF; Lee MS; Huang YY; Chang PJ
BMC Musculoskelet Disord; 2016 Jul; 17():286. PubMed ID: 27421654
[TBL] [Abstract][Full Text] [Related]
6. External fixation of tibial pilon fractures and fracture healing.
Ristiniemi J
Acta Orthop Suppl; 2007 Jun; 78(326):3, 5-34. PubMed ID: 17465283
[TBL] [Abstract][Full Text] [Related]
7. Pulsed electromagnetic field stimulation for acute tibial shaft fractures: a multicenter, double-blind, randomized trial.
Adie S; Harris IA; Naylor JM; Rae H; Dao A; Yong S; Ying V
J Bone Joint Surg Am; 2011 Sep; 93(17):1569-76. PubMed ID: 21915570
[TBL] [Abstract][Full Text] [Related]
8. Treatment of nonunions with nonglycosylated recombinant human bone morphogenetic protein-2 delivered from a fibrin matrix.
Schmökel HG; Weber FE; Seiler G; von Rechenberg B; Schense JC; Schawalder P; Hubbell J
Vet Surg; 2004; 33(2):112-8. PubMed ID: 15027972
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of recombinant human bone morphogenetic protein-2/calcium phosphate matrix for closed tibial diaphyseal fracture: a double-blind, randomized, controlled phase-II/III trial.
Lyon T; Scheele W; Bhandari M; Koval KJ; Sanchez EG; Christensen J; Valentin A; Huard F
J Bone Joint Surg Am; 2013 Dec; 95(23):2088-96. PubMed ID: 24306695
[TBL] [Abstract][Full Text] [Related]
10. Outcome of nonunion fractures in dogs treated with fixation, compression resistant matrix, and recombinant human bone morphogenetic protein-2.
Massie AM; Kapatkin AS; Fuller MC; Verstraete FJ; Arzi B
Vet Comp Orthop Traumatol; 2017 Mar; 30(2):153-159. PubMed ID: 28094415
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies.
Swiontkowski MF; Aro HT; Donell S; Esterhai JL; Goulet J; Jones A; Kregor PJ; Nordsletten L; Paiement G; Patel A
J Bone Joint Surg Am; 2006 Jun; 88(6):1258-65. PubMed ID: 16757759
[TBL] [Abstract][Full Text] [Related]
12. RhBMP-7 accelerates the healing in distal tibial fractures treated by external fixation.
Ristiniemi J; Flinkkilä T; Hyvönen P; Lakovaara M; Pakarinen H; Jalovaara P
J Bone Joint Surg Br; 2007 Feb; 89(2):265-72. PubMed ID: 17322450
[TBL] [Abstract][Full Text] [Related]
13. The effect of rhBMP-2 in a novel, non-instrumented extremity nonunion model.
Ghodasra JH; Weatherford BM; Nickoli MS; Daley EL; Chen K; Zhang LQ; Hashmi SZ; Hsu EL; Hsu WK
J Orthop Sci; 2016 Jan; 21(1):79-85. PubMed ID: 26740420
[TBL] [Abstract][Full Text] [Related]
14. Open reduction and plate fixation versus nonoperative treatment for displaced midshaft clavicular fractures: a multicenter, randomized, controlled trial.
Robinson CM; Goudie EB; Murray IR; Jenkins PJ; Ahktar MA; Read EO; Foster CJ; Clark K; Brooksbank AJ; Arthur A; Crowther MA; Packham I; Chesser TJ
J Bone Joint Surg Am; 2013 Sep; 95(17):1576-84. PubMed ID: 24005198
[TBL] [Abstract][Full Text] [Related]
15. Clinical applications of growth factors in bone injuries: experience with BMPs.
Ronga M; Fagetti A; Canton G; Paiusco E; Surace MF; Cherubino P
Injury; 2013 Jan; 44 Suppl 1():S34-9. PubMed ID: 23351868
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein-2 compared to autologous iliac crest bone graft in the treatment of long bone nonunion.
Tressler MA; Richards JE; Sofianos D; Comrie FK; Kregor PJ; Obremskey WT
Orthopedics; 2011 Dec; 34(12):e877-84. PubMed ID: 22146205
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human bone morphogenetic proteins in the treatment of fractures.
Kain MS; Einhorn TA
Foot Ankle Clin; 2005 Dec; 10(4):639-50, viii. PubMed ID: 16297824
[TBL] [Abstract][Full Text] [Related]
18. No advantage to rhBMP-2 in addition to autogenous graft for fracture nonunion.
Takemoto R; Forman J; Taormina DP; Egol KA
Orthopedics; 2014 Jun; 37(6):e525-30. PubMed ID: 24972432
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory response to recombinant human bone morphogenetic protein-2 use in the treatment of a proximal humeral fracture: a case report.
Julka A; Shah AS; Miller BS
J Shoulder Elbow Surg; 2012 Jan; 21(1):e12-6. PubMed ID: 21795067
[No Abstract] [Full Text] [Related]
20. Bone morphogenetic protein but not transforming growth factor-beta enhances bone formation in canine diaphyseal nonunions implanted with a biodegradable composite polymer.
Heckman JD; Ehler W; Brooks BP; Aufdemorte TB; Lohmann CH; Morgan T; Boyan BD
J Bone Joint Surg Am; 1999 Dec; 81(12):1717-29. PubMed ID: 10608383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
